Hotta, N., Kawamori, R., Fukuda, M., & Shigeta, Y. (2012). Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: Multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Blackwell Publishing Ltd.
Style de citation ChicagoHotta, N., R. Kawamori, M. Fukuda, et Y. Shigeta. Long-term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, On Progression of Diabetic Neuropathy and Other Microvascular Complications: Multivariate Epidemiological Analysis Based On Patient Background Factors and Severity of Diabetic Neuropathy. Blackwell Publishing Ltd, 2012.
Style de citation MLAHotta, N., R. Kawamori, M. Fukuda, et Y. Shigeta. Long-term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, On Progression of Diabetic Neuropathy and Other Microvascular Complications: Multivariate Epidemiological Analysis Based On Patient Background Factors and Severity of Diabetic Neuropathy. Blackwell Publishing Ltd, 2012.